- Home
- MLYS vs BRKL Comparison
MLYS vs BRKL Comparison
Compare MLYS & BRKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLYS
- BRKL
- Stock Information
- Founded
- MLYS 2019
- BRKL 1871
- Country
- MLYS United States
- BRKL United States
- Employees
- MLYS N/A
- BRKL N/A
- Industry
- MLYS Biotechnology: Pharmaceutical Preparations
- BRKL Savings Institutions
- Sector
- MLYS Health Care
- BRKL Finance
- Exchange
- MLYS Nasdaq
- BRKL Nasdaq
- Market Cap
- MLYS 1.0B
- BRKL 897.3M
- IPO Year
- MLYS 2023
- BRKL 1998
- Fundamental
- Price
- MLYS $15.58
- BRKL $10.33
- Analyst Decision
- MLYS Strong Buy
- BRKL Buy
- Analyst Count
- MLYS 3
- BRKL 2
- Target Price
- MLYS $33.00
- BRKL $15.25
- AVG Volume (30 Days)
- MLYS 866.7K
- BRKL 485.2K
- Earning Date
- MLYS 05-12-2025
- BRKL 07-23-2025
- Dividend Yield
- MLYS N/A
- BRKL 5.22%
- EPS Growth
- MLYS N/A
- BRKL N/A
- EPS
- MLYS N/A
- BRKL 0.82
- Revenue
- MLYS N/A
- BRKL $338,567,000.00
- Revenue This Year
- MLYS N/A
- BRKL $53.95
- Revenue Next Year
- MLYS N/A
- BRKL $37.82
- P/E Ratio
- MLYS N/A
- BRKL $12.60
- Revenue Growth
- MLYS N/A
- BRKL N/A
- 52 Week Low
- MLYS $8.24
- BRKL $8.01
- 52 Week High
- MLYS $18.38
- BRKL $13.15
- Technical
- Relative Strength Index (RSI)
- MLYS 54.41
- BRKL 43.33
- Support Level
- MLYS $15.45
- BRKL $10.32
- Resistance Level
- MLYS $16.11
- BRKL $10.63
- Average True Range (ATR)
- MLYS 0.96
- BRKL 0.22
- MACD
- MLYS -0.05
- BRKL -0.06
- Stochastic Oscillator
- MLYS 51.56
- BRKL 12.50
About MLYS Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
About BRKL Brookline Bancorp Inc.
Brookline Bancorp Inc operates as a multi-bank holding company. It offers commercial, business, and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans.